CIK 0000318154 · Large accelerated filer
AMGEN INC
Sign in to watch- Ticker
- AMGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 953540776
- Phone
- (805)447-1000
- Business address
- ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
- 8-K Event Agreement ended
- 4 Open-market sale SVP & CCO sold 3,139 shares at $337.26 ($1,058,667)
- 144 Insider Sale of Securities
- 4 Open-market sale SVP, Business Development sold 890 shares at $336.24 ($299,256)
- 4 Open-market sale EVP, Global Commercial Ops sold 6,879 shares at $336.83 ($2,317,071)
- 4 Gift EVP & Chief Technology Officer gave 6,799 shares (gift)
- 4 Grant or award Director acquired 218.61 shares (grant or award)
- 4 Grant or award Director acquired 265.46 shares (grant or award)
- 4 Grant or award Director acquired 218.61 shares (grant or award)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes SVP, Business Development gave up 226 shares (to pay taxes)
- 4 Shares withheld for taxes VP, Finance & CAO gave up 202 shares (to pay taxes)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market sale SVP & CCO sold 1,267 shares at $296.99 ($376,280)
- 144 Insider Sale of Securities
- 4 Grant or award Director acquired 121.43 shares (grant or award)
- 4 Grant or award Director acquired 147.45 shares (grant or award)
Page 7 of 161 · 3,201 filings